REFERENCES
- Kimura SJ, Hogan MJ, Thygeson P. Fuchs’ syndrome of heterochromic cyclitis. AMA Arch Ophthalmol. 1955;54:179–186.
- La Hey E, Baarsma GS, De Vries J, et al. Clinical analysis of Fuchs’ heterochromic cyclitis. Doc Ophthalmol. 1991;78:225–235.
- Javadi MA, Jafarinasab MR, Araghi AA, et al. Outcomes of phacoemulsification and in-the-bag intraocular lens implantation in Fuchs’ heterochromic iridocyclitis. J Cataract Refract Surg. 2005;31:997–1001.
- Ram J, Kaushik S, Brar GS, et al. Phacoemulsification in patients with Fuchs’ heterochromic uveitis. J Cataract Refract Surg. 2002;28:1372–1378.
- Scott RA, Sullivan PM, Aylward GW, et al. The effect of pars plana vitrectomy in the management of Fuchs heterochromic cyclitis. Retina. 2001;21:312–316.
- Tejwani S, Murthy S, Sangwan VS. Cataract extraction outcomes in patients with Fuchs’ heterochromic cyclitis. J Cataract Refract Surg. 2006;32:1678–1682.
- Waters FM, Goodall K, Jones NP, et al. Vitrectomy for vitreous opacification in Fuchs’ heterochromic uveitis. Eye (Lond). 2000;14:216–218.
- Jones NP. Glaucoma in Fuchs’ Heterochromic uveitis: aetiology, management and outcome. Eye (Lond). 1991;5:662–667.
- Liesegang TJ. Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol. 1982;100:1622–1626.
- You YA, Wu Y, Hu S. Surgical management of secondary glaucoma in Fuchs’ heterochromic iridocyclitis. Graefes Arch Clin Exp Ophthalmol. 2013;251:1785–1790.
- Voykov B, Deuter C, Zierhut M, et al. Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs’ uveitis syndrome? Graefes Arch Clin Exp Ophthalmol. 2014;252:485–489.
- La Hey E, de Vries J, Langerhorst CT, et al. Treatment and prognosis of secondary glaucoma in Fuchs’ heterochromic iridocyclitis. Am J Ophthalmol. 1993;116:327–340.
- Ceballos EM, Parrish RK 2nd, Schiffman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology. 2002;109:2256–2260.
- Gil-Carrasco F, Salinas-VanOrman E, Recillas-Gispert C, et al. Ahmed valve implant for uncontrolled uveitic glaucoma. Ocul Immunol Inflamm. 1998;6:27–37.
- Molteno AC, Sayawat N, Herbison P. Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology. 2001;108:605–613.
- Ozdal PC, Vianna RN, Deschenes J. Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye (Lond). 2006;20:178–183.
- Papadaki TG, Zacharopoulos IP, Pasquale LR, et al. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144:62–69.
- Rachmiel R, Trope GE, Buys YM, et al. Ahmed glaucoma valve implantation in uveitic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol. 2008;43:462–467.
- Da Mata A, Burk SE, Netland PA, et al. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology. 1999;106:2168–2172.
- Bonfioli AA, Curi AL, Orefice F. Fuchs’ heterochromic cyclitis. Semin Ophthalmol. 2005;20:143–146.
- Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology. 1998;105:1968–1976.
- Lai JS, Poon AS, Chua JK, et al. Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma. Br J Ophthalmol. 2000;84:718–721.
- Eibschitz-Tsimhoni M, Schertzer RM, Musch DC, et al. Incidence and management of encapsulated cysts following Ahmed glaucoma valve insertion. J Glaucoma. 2005;14:276–279.
- Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma. 2001;10:237–249.
- Budenz DL, Barton K, Gedde SJ, et al. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2015;122:308–316.
- Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153:789–803.
- Cantor L, Burgoyne J, Sanders S, et al. The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. J Glaucoma. 1998;7:240–246.
- Costa VP, Azuara-Blanco A, Netland PA, et al. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology. 2004;111:1071–1076.
- Lee D, Shin DH, Birt CM, et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology. 1997;104:2126–2135.
- Trible JR, Brown DB. Occlusive ligature and standardized fenestration of a Baerveldt tube with and without antimetabolites for early postoperative intraocular pressure control. Ophthalmology. 1998;105:2243–2250.
- Alvarado JA, Hollander DA, Juster RP, et al. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes. Am J Ophthalmol. 2008;146:276–284.
- Chen PP, Palmberg PF. Needling revision of glaucoma drainage device filtering blebs. Ophthalmology. 1997;104:1004–1010.
- Schaefer JL, Levine MA, Martorana G, et al. Failed glaucoma drainage implant: long-term outcomes of a second glaucoma drainage device versus cyclophotocoagulation. Br J Ophthalmol. 2015;99:1718–1724.
- Geffen N, Buys YM, Smith M, et al. Conjunctival complications related to Ahmed glaucoma valve insertion. J Glaucoma. 2014;23:109–114.
- Huang MC, Netland PA, Coleman AL, et al. Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1999;127:27–33.
- Topouzis F, Coleman AL, Choplin N, et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1999;128:198–204.